ADALIMUMAB (HUMIRA®) THERAPY IMPROVES INFLAMMATORY BOWEL DISEASE (IBD) AND PSORIASIS (PS) IN PATIENTS WITH ANKYLOSING SPONDYLITIS (AS)

J. Braun, I. Olivieri, K. Boki, S. Kary, H. Kupper, M. RudwaleitRheumazentrum Ruhrgebiet, Herne, Germany; Ospedale San Carlo di Potenza, Córdoba, Spain; Sismanoglio Hospital, Athens, Greece; Abbott GmbH & Co KG, Ludwigshafen; Charité – University Medicine Berlin, Berlin, GermanyCitation: Ann Rheum Dis, volume 67, supplement II, year 2008, page 623Session: Spondylarthropathies